ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system utilizes our spine’s natural anatomy for spinal stability.
The system offers all around benefits to the $2.2 billion worldwide addressable spine market.
ZygoFix is a privately held company, founded in 2017 by Professor Yizhar Floman and Uri Arnin.
Improve spinal fusion clinical outcomes in the most minimally invasive fashion by providing solutions aligned with our natural anatomy.
Board of Directors
ZygoFix enjoys the great support of our investor, Trendlines, in all descisions and operation.
Barak Singer, CEO Trendlines Incubator and Ofir Hazut, VP BD of Trendlines Incubator sit at our board along with industry executive John E. Hart and with co-founders Uri Arnin and Prof. Yizhar Floman.
Ofir Hazut has over 12 years of experience and knowledge in life science start-ups and companies. He served as Director of Business Development and CEO in medical devices and agrotech companies. Prior to joining Trendlines, Ofir held the position of Director of Business Development at Evogene and CEO of MEway Pharma, a medical device company funded by Sanara Ventures (a medical incubator backed by Phillips and TEVA). Ofir Hazut advised VCs in investment strategy, deal flow and due diligence processes.
Ofir received his B.Sc in Neuroscience and MBA from Bar-Ilan University and M.Sc in Bio-Psychology from Tel-Aviv University.
Barak Singer has over 15 years of experience in management, business development, investment banking, and venture capital.
Among others, Barak served as VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix, VP Business Development at Xenia Venture Capital, and was a Co-Founder and CEO at Or Capital Healthcare Partners.
Barak currently serves as the CEO of Trendlines Israel Incubator.
John E. Hart
John Hart brings over 35 years of executive leadership experience leading global medical device company growth and performance. In his last role, John helped lead CONMED Corporation's turnaround by leading the Cardiology and Critical Care business unit from historically negative to double digit growth and the Healthcare Solutions Team to an increased number of corporate and national contracts. Prior to that, John led VIDAR Systems Corporation and ISTO Technologies to successful M&A executions. John has also held executive positions with Stryker Orthopaedics, U.S. Surgical (now Medtronic) and J&J.